Alan Bougen - Comvita Limited Insider |
| Comvita Limited -- USA Stock | USD 3.74 0.00 0.00% |
Non-Executive Deputy Chairman of the Board
Mr. Alan John Bougen is no longer a NonExecutive Deputy Chairman of the Board of Comvita Limited., effective October 2017. He having been a foundation Director since 1976 and serving as Managing Director until 1998. His background in the natural healthcare industry, apiculture and international marketing, brings a particularly pertinent industry and global perspective to the Board as Comvita continues in the developments of its key offshore markets. Alan is a member of the Institute of Directors and operates his own consultancy business which includes directorships in other private companies.64 7 533 1426 http://www.comvita.co.nz
Management Efficiency
The company has return on total asset (ROA) of 0.25 % which means that it generated profit of $0.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 6.64 % meaning that it generated $6.64 on every $100 dollars invested by stockholders.The company has accumulated 48.14 M in total debt with debt to equity ratio (D/E) of 40.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Comvita Limited has Current Ratio of 5.88 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Similar Executives
| Found 1 records | CHAIRMAN Since | |
| Manuel Pangilinan | Metro Pacific Investments Corpo | 2006 |
Entity Summary
Comvita Limited manufactures and markets natural health products. Comvita Limited (CVNZF) is traded on OTC Market in USA. It is located in Te Puke, and employs 500 people.
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Comvita Limited to your portfolio
Top Management
Comvita Limited Leadership Team
| Sarah Ottrey, Director | |
| PostGradDip BCom, Executive | |
| Ben Shaw, Executive | |
| Paul Reid, Director | |
| Roy Ong, Executive | |
| Patrick Brus, Executive | |
| Lucas Bunt, Director | |
| Sharon Hollenstein, Executive | |
| Julianne Keast, CFO | |
| Thomas Cullwick, Director | |
| GradDipFin BBS, CEO | |
| Kate Selway, Executive | |
| Edward Quilty, Director | |
| RalfChristian Schlothauer, Executive | |
| Julie Chadwick, Executive | |
| Simon Pothecary, Executive | |
| Alan Bougen, Chairman | |
| Maurice Prendergast, Director | |
| Scott Coulter, CEO | |
| Murray Denyer, Director | |
| Brett Hewlett, CEO | |
| Mark Sadd, Executive | |
| Neil Craig, Chairman | |
| MBA DipT, Executive | |
| Sarah Kennedy, Director | |
| Colin Baskin, Executive |
Stock Performance
Comvita Limited Performance Indicators
| Return On Equity | 6.64 % | ||
| Return On Asset | 0.25 % | ||
| Profit Margin | 6.3 % | ||
| Operating Margin | 0.64 % | ||
| Current Valuation | 201.93 M | ||
| Price to Earning | 22.26 times | ||
| Price to Book | 1.32 times | ||
| Price to Sales | 2.04 times | ||
| Revenue | 112.85 M | ||
| Gross Profit | 62 M |